Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
9/11/25 Merck & Co (MRK) Capvaxive for Pneumococcal (Streptococcus pneumoniae) Vaccines (Antibacterial) Subscribers Only Subscribers Only Subscribers Only
9/10/25 Avidity Biosciences (RNA) Del-zota for Duchenne Muscular Dystrophy (DMD) Subscribers Only Subscribers Only Subscribers Only
9/8/25 Rapport Therapeutics (RAPP) RAP-219 for Partial / Focal Seizures (Epilepsy) Subscribers Only Subscribers Only Subscribers Only
9/8/25 BioNTech (BNTX) pumitamig for Small Cell Lung Cancer (SCLC) Subscribers Only Subscribers Only Subscribers Only
9/8/25 Dianthus Therapeutics (DNTH) claseprubart for Myasthenia Gravis (MG) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/26/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/08/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/11/2025 Subscribers Only Subscribers Only Trial Data - Updated Results